What is Vyv?
Vyv operates at the intersection of public health and advanced lighting technology, offering a sophisticated alternative to traditional, intermittent cleaning methods. By deploying light-based solutions that are safe for human exposure, the company addresses the inherent limitations of chemical sprays and hazardous UV-C systems. Vyv's core value proposition lies in its ability to provide continuous, automated surface protection, effectively mitigating the presence of bacteria and viruses in high-traffic environments. This approach not only enhances operational efficiency for facility managers but also establishes a new standard for hygiene in the built environment, prioritizing both human safety and environmental sustainability.
How much funding has Vyv raised?
Vyv has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Vyv
PPP
Public-Private Partnership
What's next for Vyv?
With this late-stage capital, Vyv is positioned to accelerate its market penetration and expand its manufacturing capabilities to meet rising global demand. The strategic focus will likely shift toward deepening its integration within healthcare, education, and corporate infrastructure, where the requirement for persistent, non-toxic disinfection is paramount. By leveraging this financial backing, the company aims to solidify its leadership position in the antimicrobial lighting sector, potentially exploring new product iterations that further reduce the reliance on manual cleaning protocols. As Vyv scales, the focus will remain on proving the long-term efficacy of its technology in real-world, high-density settings, thereby validating its role as a foundational component of modern public health infrastructure.
See full Vyv company page
